POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS : II. THE CELLULAR SOURCE OF POTENTIATING MEDIATOR(S) by Gery, Igal & Waksman, Byron H.
POTENTIATION  OF  THE  T-LYMPHOCYTE  RESPONSE 
TO  MITOGENS 
II. THE  CELLULAR  SOURCE  OF POTENTIATING  MEDIATOR(S)* 
BY IGAL GERY$ AND BYRON  H. WAKSMAN 
(From the Department o/ Microbiology,  Yale University School of Medicine, 
New Haven, Connecticut 06510) 
(Received for publication 25 February  1972) 
The first papers of the present series  establish that mouse thymocytes and 
peripheral  thymus-processed (T) 1 lymphocytes are stimulated to mitosis and 
their response  to  such  agents as phytohemagglutinin greatly potentiated by 
factor(s)  designated  "lymphocyte-activating factor"  (LAF),  which  are  pro- 
duced  in  cultures  of  syngeneic or  xenogeneic lymphoid cells  (1,  2).  In  this 
paper,  we present data showing that  adherent  cells,  probably macrophages, 
are the principal source of LAF and that its production is increased by agents 
which stimulate these cells. 
Materials and Methods 
Animals.--Male or female CBA/J mice, 6-12 wk of age, were used without treatment or 
after irradiation (850 R) and reconstitution with 5 )< 106 syngeneic bone marrow cells (XBM), 
5-8 X  l0  T thymocytes (XT), or both bone marrow and thymus cells (XBMT). Young adult 
New Zealand albino rabbits of both sexes were purchased from a local dealer and used with- 
out treatment. 
Cell Preparation and Culture.--All  the materials and techniques employed for cell prepara- 
tion and culture are fully described in our previous papers  (1-3). The separation of adherent 
from nonadherent cells was carried out both on plastic (4, 5) and by the use of nylon columns 
(6, 7). While 8% pooled normal human serum was routinely used for lymphocyte culture, the 
adherence technique required higher concentrations,  10% human serum being used routinely 
and  10% fetal calf serum  (Grand Island Biological Company,  Grand Island,  N.Y.)  in one 
experiment. 
I%E  SLrLTS 
Release  of  Potentiating  Factors by  Cells from  Different  Sources.--Factors 
stimulatory to normal CBA thymocytes are released by normal human, rabbit, 
* Supported by US Public Health Service Grants AI-06112  and AI-06455. 
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1  Abbreviations used in this paper: B, nonthymus processed; Con A, concanavalin A; LAF, 
lymphocyte-activating factor; LPS, lipopolysaccharide; PBL, peripheral blood lymphocytes; 
PHA, phytohemagglutinin;  SUP, supernatant;  T,  thymus processed; T-3H,  thymidine-aH; 
XBM, irradiation plus syngeneic bone marrow cells; XBMT, irradiation plus syngeneic bone 
marrow cells and thymocytes; XT, irradiation plus syngeneic thymocytes. 
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or  syngeneic mouse  lymphoid  cells  into  the  supernatant  (SUP)  (Table  I). 
Human peripheral blood lymphocytes (PBL), acted on by phytohemagglutinin 
(PHA)  or lipopolysaccharide  (LPS),  produce  SUP  which  is  mitogenic  alone 
and which greatly potentiates the thymocyte response to PHA. The production 
of  SUP  activity bears  no  relation  to  DNA  synthesis  in  the  donor  culture, 
which is marked with  PHA and negligible  with respect to LPS.  Concanavalin 
A  (Con A), which was mitogenic for the donor culture,  gave no SUP activity 
in this experiment. 
With syngeneic spleen cells, all three mitogens stimulate mitosis and produc- 
tion  of  SUP  activity but  at  a  lesser  level  than  with  human  cells.  Only Con 
TABLE I 
Response  to  Stimztlants  and  Production  of Potentiating  Factors  by  Cells  of Different Species 
Experiment 
Donor culture  Recipient culture* T-"H uptake 
Cells  Stimulant  T-all uptake  SUP alone  SUP q- PHA 
II 
None  --  --  29  242 
Human blood leuko-  None  63  28  488 
cytes  PHA  64,492  14,880  38,418 
LPS  747  13,426  53,898 
Con A  2,426  73  368 
Mouse spleen cells  None  355  42  417 
PHA  17,003  109  1,224 
LPS  55,697  147  14,811 
Con A  85,200  1,091  9,090 
None  --  --  147  665 
Rabbit spleen cells  None  1,391  265  1,305 
PHA  6,154  519  1,551 
LPS  1,856  520  4,637 
* Mouse thymocytes. 
A-SUP  stimulates  DNA  synthesis  in  recipient  thymocytes  without  added 
PHA. Rabbit spleen  cells  give similar findings but a  still  lower level  of SUP 
production. However, rabbit cells were agglutinated to some extent by human 
serum  in  the medium,  and  SUP production may have been  affected by this. 
LPS was clearly the best stimulant  of SUP production with all  the cell  types 
tested. 
When  mouse  organs  are  compared  (Table  II),  bone  marrow,  spleen,  and 
thymus,  in  that  order,  are  found  to  contain  cells  active  in  producing SUP. 
Some is released by unstimulated cells, more by cells exposed to PHA or Con 
A, and the most by cells treated with LPS. Only LPS was effective in stimulat- 
ing marrow to produce an active SUP. While all the supernatants tested acted 
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marrow were mitogenic  alone,  in  each  case more so  than  PHA.  Again there 
was no correlation between  donor cell mitosis  and production of SUP. 
Characterization  of Cells which Produce Potentiating Factors.--Lethal  irradi- 
ation  of  mouse  donors  and  reconstitution  with  bone  marrow  alone  did  not 
significantly affect  the  ability  of their  spleen  cells  to produce SUP,  when  in- 
cubated without  stimulant  or with LPS  (Table  III). With  PHA and  Con A, 
on the other hand,  there was some loss of ability  to form SUP,  and  this  was 
restored  by the  additional  injection  of thymocytes. These  data  and  those  of 
TABLE II 
Response to Stimulants  and Production of Potentiating Factors by Cells of Different Manse 
(Syngeneic) Organs 
Donor culture  Recipient culture  T-all uptake 
Experiment 
Cell source  Stimulant  T-ZH uptake  SUP alone  SUP -I- PHA 
II 
--  --  --  55  557 
Spleen  None  1,763  80  1,367 
PHA  42,061  183  3,919 
LPS  60,635  419  13,568 
Con A  112,606  5040  12,984 
Thymus  None  35  76  803 
PHA  456  146  1,141 
LPS  337  247  3,892 
Con A  7,108  199  886 
--  --  --  69  1,693 
Spleen  None  231  56  3,046 
PHA  35,780  364  4,285 
LPS  61,310  632  23,529 
Con A  158,447  7125  25,406 
Bone marrow  None  3,336  45  2,741 
PHA  11,143  209  4,073 
LPS  10,663  5008  33,676 
Con A  11,328  369  4,883 
Table II imply that T  lymphocytes may contribute to the formation of active 
SUP with PHA and Con A but not with LPS. 
When  mouse  spleen  cells  were  separated  into  adherent  and  nonadherent 
populations by incubation in plastic Petri dishes,  the ability to produce mito- 
genic and potentiating  SUP, after stimulation with Con A  and especially with 
LPS,  was  found  to  reside  almost  entirely  in  the  adherent  cells  (Table  IV). 
When  the  adherent  cells  were  cultured  for 2  days  and  washed  repeatedly  to 
remove cells other than macrophages, they remained active as sources of SUP. 
At  this  time  contamination  with  granulocytes  and  lymphocytes is  minimal. 
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colunms. These cells retained their reactivity with PHA,  as shown by thymi- 
dine-3H (T-3H) uptake after 3 days in culture, yet lost to a considerable degree 
their  ability to  produce  mitogenic or  potentiating factors  when  stimulated 
with either PHA or LPS  (Table V). Titrations indicated that column-purified 
TABLE  III 
Response to Stimulants  and Prod,uction of Potentiating Factors by Syngeneie Normal,  XBM, 
and XBMT Spleen Cells 
Donor culture  Recipient culture T-~H uptake 
Treatment of mouse  Stimulant  T-~H uptake  SUP alone  SUP +  PHA 
--  --  --  45  879 
Normal  None  221  23  1,015 
PHA  22,025  136  2,132 
LPS  38,201  125  8,432 
Con A  115,712  3413  14,364 
XBM  None  1,15l  44  1,608 
PHA  6,484  95  2,458 
LPS  1,582  179  11,829 
Con A  10,653  641  5,137 
XBMT  None  2,552  38  2,746 
PHA  21,705  233  6,227 
LPS  4,872  1048  13,832 
Con A  50,981  3028  13,702 
TABLE  IV 
Prodnction of Potentiating Mediators by Adherent and Nonadherent Mouse Spleen Cells 
Mouse spleen fraction 
Stimulant of donor  PHA in recipient 
culture  culture  Original  Nonadherent  Adherent (1 hr)  Adherent 
(2 days) 
None  --  30*  48  37  ND 
-1-  238  157  789  ND 
LPS  --  76  42  3,112  173 
-k  2258  759  15,326  7992 
Con A  --  401  92  541  ND 
-I-  1662  258  3,665  ND 
* Values for T-3H uptake (counts per minute)  in recipient thymocyte  cultures without 
added SUP were unstimulated,  55, and PHA-stlmulated, 293. 
cells produced less than 4%  of the SUP activity released by the original un- 
fractionated PBL. The residual activity did not disappear on dilution and may 
differ qualitatively from that obtained with unpurified cells. 
The  Indirect  Action  of  Milogens.--Removal  of  adherent  cells  from  a 
normal  CBA  th3~nocyte  population  reduces  the  response  of  these  cells  in 
culture (T-3H uptake) to PHA and Con A to less than one-half of control values I,  GERY  AND  ]3.  I-I.  WAKSMAN  147 
and  virtually eliminates  the  response  to  LPS  (Table  VI).  The  supernatants 
after treatment  of control cultures with any of the three mitogens show  SUP 
activity,  and  comparable  activity  is  much  reduced  in  the  supernatants  of 
nonadherent cells in culture (data not shown). 
,  Quantitative Comparison of Different Supernatants.--A  comparative titration 
was carried out on two active SUP obtained from human PBL stimulated with 
PHA and LPS (Fig. 1). Both were mitogenic alone for mouse thymocytes, and 
both  enhanced  the response  of these  cells to  PHA.  Enhancement  was  signifi- 
TABLE V 
Effect of Nylon Column Purification on Ability of Human Blood Leukocytes to Produce 
Potentiating Factors 
Donm culture  Recipient culture 
Experiment  SUP dilution  T-all uptake 
Cells  Stimulant  T-3H uptake  SUP alone  SUP +  PHA 
II 
None  --  --  --  64  1,032 
Original  None  29  Undiluted  3,748  30,139 
1:5  202  12,853 
PHA  15,869  Undiluted  19,942  51,858 
1:5  1,214  20,073 
1:25  155  6,148 
LPS  25  Undiluted  13,656  56,126 
1:5  6,071  39,127 
1:25  1,511  21,831 
Purified  None  38  --  ND  ND 
PHA  7,859  Undiluted  125  1,900 
1:5  57  1,718 
LPS  21  Undiluted  122  3,655 
1:5  100  3,084 
None  --  --  --  53  525 
Original  None  60  Undiluted  87  833 
PHA  45,855  Undiluted  27,529  31,518 
Purified  None  --  ND  ND 
PHA  26,210  Undiluted  200  1,409 
cant  at concentrations  of SUP  below the mitogenic threshhold.  The  maximal 
level of  enhanced  stimulation attained was  only slightly greater in  each  case 
than that achieved with the optimal concentration of SUP alone. The titration 
curves,  both  for  SUP  alone  and  for  SUP  +  PHA,  were  closely similar  and 
suggested that the same active agent was present in the two preparations. 
DISCUSSION 
In  the  previous paper  (2),  evidence was  presented  that  the  target  cell for 
LAF is the central or peripheral thymus-processed (T)  lymphocyte. The data 
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both  human and mouse  cultures.  Active SUP  were  obtained from  adherent 
cells,  which  could  be  maintained for  2  days  attached  to  plastic  and  which 
withstood  vigorous  washing.  Such  preparations  do  not  include  significant 
numbers of T  cells, nor do spleen cell suspensions from XBM mice, which also 
TABLE  VI 
Stimulation of Mouse Thym~ts Cells by LPS: the Need for Adherent  Cells 
T-all uptake by thymus cells 
Stimulant  Ratio original/nonadherent 
Original  Nonadherent* 
None  130  20  6.5 
LPS  343  81  4.2 
PHA  441  178  2.5 
LPS Jr- PHA  1527  274  5.6 
Con A  5844  2606  2.2 
* Collected after two incubations in Petri dishes. 
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Dilufion  of  SUP edded to culture 
FIO. 1.  Titration of mitogenic and potentiating activity of SUP prepared by incubating 
PBL with PHA (A) or LPS  (~). T-~H-incorporation of mouse thymocytes without  addi- 
tives ..... , with PHA  - - -, with SUP ..... , or with SUP -I- PHA ---- 
produced SUP as active as  that from normal spleen. T  cells may play an in- 
direct role, nevertheless, when PHA or Con A is used to stimulate LAF produc- 
tion by macrophages (see below), and this may account in part for differences 
in LAF  production by  different organs  stinmlated with  the  various  agents. 
Nonthymus processed  (B)  cells  appear  to  be  ruled  out  as  a  source  of  LAF 
since active SUP  could  be  obtained from  thymus cell  suspensions and from i.  GERY  AND  13.  1-[.  WAKSMAN  149 
XBM spleen at a  time when no B  ceils  reactive to LPS are present (3). The 
most  active  SUP  were  obtained  with  LPS,  a  well-recognized stimulant  of 
macrophages (8-11). 
There is no evidence that LAF produced by "unstimulated" adherent cells 
differs qualitatively from that produced after stimulation with PHA or LPS 
or that  the latter are different from each other. All are mitogenic alone and 
show striking synergy with PHA or with Con A used at concentrations below 
those giving a maximal response. Their titration curves, alone or in the presence 
of PHA,  are  perfectly parallel  (Fig.  1).  Apparent  qualitative  differences in 
SUP from different animal  species  and different organs  are most  readily ex- 
plained  as  depending  on  differences in  LAF  concentration.  Also,  as  noted, 
differences in  the  number  of T  cells  influence LAF  production  by PHA  or 
Con A as compared with LPS. There may" nevertheless be some heterogeneity 
of factors  which  act  on  lymphocytes. We  have  seen  (Table  V)  that  nylon 
column-purified PBL  can  be  stimulated  by LPS  to  produce weakly  active 
SUP whose activity resists dilution. Tridente et al.  (12,  13)  and Winkelstein 
(14) have described synergistic responses of thymocytes with other cells having 
different kinetic properties from those under consideration here, and the former 
group reports that  the adherent cells from bone marrow are less  effective in 
stimulating thymocytes than unfractionated marrow cells. 
The present observations suggest that LAF :nay play an  essential  role in 
many or all the immunologic responses in which T  cells participate, certainly 
in  each  instance  where  a  requirement for macrophages  or  "adherent  cells" 
has been demonstrated. Such a  requirement in the reaction of the sensitized 
cells  of  delayed  hypersensitivity  with  eliciting  antigen  is  well  recognized, 
whether  this  be measured  by proliferation and  blast  transformation  (6)  or 
by production of secondary mediators such as lymphotoxin3 Equally important 
is  the primary response of unimmunized T  cells,  as  in  the graft-versus-host 
reaction and its in vitro equivalent, the mixed lymphocyte reaction (15,  16), 
or the response to an immunizing dose of soluble antigen with adjuvant (17).  a 
In such primary responses, a further cooperation between T  cells of different 
biologic types or specificities may be essential (18,  19).  Finally, the coopera- 
tion of T  and B  cells (20,  21) in stimulating the latter to plasma cell transfor- 
mation and antibody production requires macrophages both in vivo (22)  and 
in vitro (4, 5, 23-27). In several of these instances involving T  cells alone (16, 
28)  or T-B  cell cooperation (24,  25,  29)  it has  already been recognized that 
soluble factors comparable to LAF serve as mediator. This conclusion does not 
necessarily  conflict with  other  suggested  mechanisms  of  macrophage  action 
in the immune response. Supernatant factors described by other investigators 
appear in some instances to represent altered antigen (25,  29).  There is per- 
Yoshinaga, M. Unpublished data. 
3 Spiesel, S. Z., R. K. Gershon,  and B. H. Waksman. Adjuvant effects on mouse thymus- 
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suasive evidence that  antigen  attached  in  or near the cell  surface of macro- 
phages may act as "superantigen"  (30-33) or that antigen linked to a special 
RNA provided by the macrophage may play this role (34-38). 
One of the most important implications of the present observations concerns 
the role of macrophages in the action of adjuvants, whether to increase delayed 
sensitization or to enhance antibody production. In the intact animal (10, 39) 
some adjuvant materials, such as mineral oil, simply promote wide dissemina- 
tion  and  long persistence of the  antigenic stimulus.  Others  increase  the flux 
of lymphocytes into thymus-dependent areas of stimulated peripheral lymph 
nodes (40), a localization which may depend on specific as well as nonspecific 
elements in the local response to antigen and adjuvant and a release of medi- 
ators  (41,  42). Adjuvant  effects are also observed in vitro however (43), and 
clearly must  be mediated  by more direct  cellular events.  Enhanced  antigen 
uptake by macrophages (44-46),  whether as a  result of the particulate char- 
acter of the antigen (47, 48) or of stimulation directed to the macrophage (49, 
50), was long felt to account for such effects. This mechanism accords well with 
the suggested role of the macrophage in providing superantigens  to the host 
(30,  31,  33-37).  More recently, however,  the  suggestion  was  made  that  ad- 
juvants  act  by  labilizing  macrophage  lysosomes  (51-53),  and  an  increased 
production of lysosomal enzymes does in fact result from the action of LPS 
on macrophage monolayers (ll). A  target for the released lysosomal contents 
has  not  been  identified;  it  is  possible  that  LAF  may  be  a  lysosomal factor 
the target of which is the T  lymphocyte. T  cells in XT mice synthesize DNA 
rapidly in response to in vivo stimulation with a variety of adjuvant materials, 
among them pertussis  vaccine and purified LPS? Our findings, presented in 
this  and the preceding paper,  establish  that  the stimulus  to these cells must 
be  mediated  in  part  by macrophages  and  LAF  production.  These  findings 
assume greater significance in  the light of the recent demonstration that  the 
adjuvant effect of pertussis,  LPS, Freund's  adjuvant,  or retinol on antibody 
formation requires the participation of T  cells (17, 42) and the in vitro demon- 
stration  that  phagocytic  cells  and  T  lymphocytes  together  are  required  to 
"help"  nomnitotic  B  cells  respond  to  antigens  such  as  sheep  erythrocytes 
(24, 29, 54). 
Certain stimulatory effects observed in the intact animal and in vitro appear 
to be indirect. PHA and Con A produce less effective SUP from bone marrow 
than spleen,  and its production in  the latter is lessened in XBM animals  as 
contrasted  with  XBMT  animals  (see Tables If  and  III).  This implies  that 
these mitogens,  unlike LPS  which  is  highly  effective in  producing LAF  ac- 
tivity from bone marrow and in the presumed absence of T  cells,  act in part 
by stimulating  T  lymphocytes which  then  activate macrophages with  their 
mediators and these in turn produce LAF, a striking circular mechanism. PHA 
and (?on A act only on T cells (55-59). That stimulation of T ceils may produce 
activation of maerophages  indirectly by way  of soluble mediators  has  been I.  GERY  AND  13.  H.  WAKSMAN  151 
demonstrated  repeatedly  (60--62).  Thus  the  postulated  circular  mechanism 
may come into play in any situation where T  cells are activated, for example 
in the interesting "allogeneic effect" described by Katz et al.  (63). The fact 
that mouse spleen reacts maximally to a  dose of Con A  5-10-fold lower than 
required for maximal  stimulation  of mouse  thymus  4 may simply  reflect the 
relative paucity of macrophages in  the  thymus  and  consequent weakness  of 
the  suggested  circular mechanism. Removal of macrophages and other large 
cells from reactive thymocytes on bovine serum albumin gradients has been 
shown (2, 64)  to diminish their reactivity to PHA. PHA and Con A, however, 
may also have direct effects on macrophages, and we have shown production of 
LAF from adherent cells  by the former (59). In consequence, as  one would 
predict, PHA acts as an adjuvant if administered at the correct time in rela- 
tion to antigen (see references 65 and 66 for reviews). 
The response to LPS also illustrates a  second type of indirect effect. It is 
well  recognized (8-10)  that LPS is highly stimulatory to macrophages both 
in vivo (10) or in vitro (11). In the mouse, LPS also stimulates B lymphocytes 
but has no direct action on T cells (3, 59, 67). In accord with these findings, the 
stimulation of thymocytes by LPS is  shown in the present paper to depend 
entirely on the presence of adherent cells, presumably macrophages. One must 
suppose  that  the  vigorous proliferative response  of peripheral  T  cells when 
LPS is given to XT animals  3 may also be dependent on production of small 
amounts of LAF which stimulate these cells. 
SUMMARY 
Effective  supernatants  (SUP),  which  potentiate  mouse  T-cell  responses 
to phytohemagglutin (PHA), are obtained from cells of several species (human, 
rabbit, rat, mouse) and indeed from syngeneic spleen, thymus, or bone marrow 
cells. Unstimulated cells release some SUP activity but more is produced after 
stimulation. Lipopolysaccharide (LPS)  produced very active SUP  in  all  cul- 
tures  tested.  PHA  was  similarly active on  human  leukocytes only, whereas 
concanavalin A  (Con A)  gave highly  efficient SUP  only with  mouse  spleen 
cells.  SUP production is not correlated with a  mitotic response of the donor 
cells and is observed in cultures unable to respond mitotically to the stimulant. 
Adherent mouse spleen cell populations, consisting largely or entirely of macro- 
phages, produce active SUP, while nonadherent cells  do not. Similarly, puri- 
fication of human  peripheral  leukocytes on nylon columns,  with  removal of 
macrophages and other adherent cells,  destroys their ability to produce SUP. 
The importance of indirect effects in stimulating mitotic responses of T  cells 
is  emphasized  by  the  fact  that  the  mitotic  response  of  mouse  thymocytes 
to LPS and its ability to potentiate the response of these cells  to PHA dis- 
appears with removal of adherent cells from the thymocyte population. Con- 
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versely the production of SUP from spleen ceils stimulated  by Con A  requires 
the presence of T  cells. 
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